Engineering Natural Killer Cells for Cancer Immunotherapy
The next frontier in cell therapy: hear how natural killer cells are being engineered to overcome tumor resistance and deliver durable responses.
13-15 October 2026 | The Royal Institution, London
)
Submit your abstract
Due to demand, we’ve reopened abstract submissions for a limited time.
Submit your research for the opportunity to present your work to the wider conference community and contribute to the conversations shaping the field.
Submit your abstract by 1 October.